🇺🇸 Dexamethasone lipid microsphere plus ropivacaine in United States

Dexamethasone lipid microsphere plus ropivacaine (Dexamethasone lipid microsphere plus ropivacaine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dexamethasone lipid microsphere plus ropivacaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dexamethasone lipid microsphere plus ropivacaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dexamethasone lipid microsphere plus ropivacaine in United States?

Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.